Multicell Technologies, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

188 documents for Multicell Technologies, Inc.

- MultiCell Technologies Inc.
MultiCell Technologies Inc. entered into a common stock purchase agreement for $25 million in stock by Fusion Capital Fund II of Chicago. Send any n...
- San Diego Business Journal
- May 22, 2006
- MultiCell Technologies, Inc. Hosts Annual Stockholder Meeting; Spotlights Recent Progress and Drug Development Pipeline for Drugs to Treat MS, Diabetes and Influenza A.
SAN DIEGO -- MultiCell Technologies, Inc. (OTCBB: MCET), a developer of therapeutics for the treatment of degenerative neurological diseases, metaboli...
- Business Wire
- May 25, 2006
- Exten Announces Merger with MultiCell Subsidiary; New Company Name Will Be MultiCell Technologies, Inc.
To download high-resolution, print-ready JPEG images, click on the thumbnail image above. WARNING: these images are very large (800K+) Click her...
- Business Wire
- March 24, 2004

- MultiCell Technologies Inc. Offers Early Solution to R&D Drug Interactions.
Business Editors WARWICK, R.I.--(BUSINESS WIRE)--Dec. 4, 2002 MultiCell Technologies Inc., a subsidiary of Exten Industries Inc. (OTCBB:EXTI), is ...
- Business Wire
- December 04, 2002
- Company Profile for Multicell Technologies, Inc.
MultiCell Technologies, Inc., (OTCBB:MUCL) provides non-tumorigenic functional hepatic (liver) cells and cell lines to pharmaceutical companies for in...
- Business Wire
- October 22, 2004
- Exten Subsidiary MultiCell Associates Inc. Changes Name to MultiCell Technologies Inc.
Business Editors/Health & Medical Writers BIOWIRE2K SAN DIEGO--(BW HealthWire)--Sept. 25, 2001 Exten Industries Inc., (Exten) (OTCBB:EXTI), anno...
- Business Wire
- September 25, 2001
- Dr. Stephen Chang, President of MultiCell Technologies Inc., Talks to The Wall Street Transcript.
NEW YORK -- The Wall Street Transcript has published an in-depth interview with Dr. Stephen Chang, President of MultiCell Technologies Inc. (OTCBB:MUC...
- Business Wire
- April 19, 2005
- Validation of Immortalized Human Hepatocytes Presented at AAPS by AstraZeneca Scientists.
LINCOLN, R.I. -- MultiCell Technologies, Inc. (OTCBB: MCET) announced that As...
- Business Wire
- November 30, 2005
- Research and Markets: Fatigue - Pipeline Review, Q1 2011 Report is not Lethargic by Any Means as it Provides a Thorough Account of Drugs in the Pipeline.
...* Sigma-Tau S.p.A. * Hemispherx Biopharma, Inc. * Anavex Life Sciences Corp. * MultiCell Technolo...
- Business Wire
- April 15, 2011
- MultiCell Technologies Releases CEO Letter to Shareholders.
...SAN DIEGO -- MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs bas...
- Business Wire
- November 27, 2006